VDT
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Mar 2025)
What this means for you
Registered since 08 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87621614
- Registration number
- 5650565
- Mark type
- Stylized text
- Filed
- 25 Sept 2017
- Published for opposition
- 19 Dec 2017
- Registered
- 08 Jan 2019
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological conditions and diseases, and pharmaceutical preparations for the treatment of chronic conditions, namely, chronic kidney disease, and all types of anemias
Owner
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 27 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 08 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Dec 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Nov 2018 — USE AMENDMENT FILED